There is a clear and urgent need to plan for endoscopy activity over the coming weeks and months. It is very difficult in these challenging and uncertain times to decide what is best for patients, the population at large and healthcare staff, and there is balance of risks to consider. As a result of multiple discussions with key stakeholder groups, the British Society of Gastroenterology (BSG) together with the Joint Advisor Group on GI endoscopy (JAG) are updating this advice to help Endosco...

Inflammatory Bowel Disease (IBD), comprising Crohn’s Disease (CD) and Ulcerative Colitis (UC), is a condition in which the gastrointestinal immune system responds inappropriately.  It is therefore often treated with immune suppression medications to control inflammation and to prevent ‘flares’, a worsening in symptoms, which may be unpredictable.

During the COVID-19 outbreak the NHS will do everything they can to keep their IBD patients safe. The biggest risks are related not only...

The British Society of Gastroenterology (BSG) together with the British Association for the Study of the Liver (BASL) and the Royal College of Physicians (RCP) have published a guide for how the health service could reduce the risk of infection for those with moderate risk inflammatory bowel disease and liver disease.  There are available equally valuable roles that can be performed without direct contact with suspected or confirmed COVID 19 patients. This advice is for patients with...

The British Society of Gastroenterology (BSL) together with the British Association for the Study of the Liver (BASL), have created a guide for all the physicians working in gastroenterology and Hepatology during the Covid-19 Pandemic. The website is often updated to give professionals the best advices. 
Click here to read the full updated publication.